Bayer and Peking University Enter Fourth Phase of Partnership to Advance Drug Discovery
Germany-based pharmaceutical giant Bayer (ETR: BAYN) has entered its fourth phase of partnership with the...
Transcenta Holding Ltd Secures Global Clinical Trial Approvals for Osemitamab in Gastric Cancer
China-based Transcenta Holding Ltd has reported receiving clinical trial approvals from China’s Center for Drug...
Pentax Medical to Establish Endoscope Manufacturing and R&D Site in Shanghai
Japan-based Pentax Medical, a division of the Hoya Group specializing in endoscopic products, has announced...
Sinopep-Allsino Bio Pharmaceutical Cuts Fundraising Target to RMB434 Million via Convertible Bonds”
Jiangsu-based Contract Development and Manufacturing Organization (CDMO) Sinopep-Allsino Biopharmaceutical Co., Ltd has revised its proposal...
Shanghai BDgene Technology Receives US FDA Approval for HSV-1 Stromal Keratitis Gene Therapy
Gene therapy specialist Shanghai BDgene Technology Co., Ltd has announced receiving approval from the US...
Jenscare Scientific’s LuX-Valve Plus Accepted for US FDA Review in IDE Process
Ningbo-based structural heart disease intervention device manufacturer, Jenscare Scientific Co., Ltd (HKG: 9877), has announced...
Broncus Medical Inc. Launches First Regulatory Clinical Study for Targeted Lung Denervation System
China-based Broncus Medical Inc., (HKG: 2216), a provider of precision intervention solutions focused on lung...
Hainan Boao Lecheng Partners with Medlive for Medical Tourism and Online Doctor Education
The Hainan Boao Lecheng International Medical Tourism Pilot Zone has entered into a strategic partnership...
HutchMed Ltd Initiates Phase I Clinical Study for SHP2 Inhibitor HMPL-415 in Solid Tumors
China-based HutchMed Ltd (NASDAQ: HCM; HKG: 0013) has announced the initiation of a Phase I...
GenScript Biotech Expands cGMP Manufacturing for Gene and Cell Therapy in Zhenjiang Facility
China-based GenScript Biotech Corporation (HKG: 1548) has announced the expansion of its current Good Manufacturing...
China’s NAFR Enhances Tax Benefits for Private Health Insurance Purchases
The National Administration of Financial Regulation (NAFR) in China has issued a Notification indicating that...
Jacobio Pharma Secures RMB 150 Million Investment to Advance Pipeline Programs
China-based Jacobio Pharma (HKG: 1167) has announced receiving RMB 150 million (USD 20.7 million) in...
Genesis MedTech Secures Chinese Market Approval for ArtiSential Laparoscopic Surgical Device
Singapore-based Genesis MedTech has announced that it has received market approval in China for its...
Shanghai Fosun Pharmaceutical Submits Daxibotulinumtoxin A (RT002) for NMPA Approval
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196), a China-based pharmaceutical company, has announced a...
Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for SHR-1703 Clinical Study
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a China-based pharmaceutical company, has announced receiving approval...
C-Mer Eye Care Holdings Ltd Partners with Hong Kong Ophthalmologist for Novel Drug Development
China-based C-Mer Eye Care Holdings Ltd (HKG: 3309) has announced the establishment of a joint...
ChengDu ShengNuo Biotechnology Aims to Raise RMB 160 Million for Peptide Drug CDMO Expansion
China-based ChengDu Shengnuo Biotechnology Co., Ltd., (SHA: 688117) has announced plans to raise up to...
Peijia Medical Receives NMPA Approval for DCwire Micro Guide Wire Device in China
Peijia Medical Ltd (HKG: 9996), a leading Chinese firm in the neurointerventional field, has announced...
Chime Biologics, Leads Biolabs, and BeiGene Form Strategic Partnership for LAG-3 mAb LBL-007
Wuhan-based Contract Development and Manufacturing Organization (CDMO) Chime Biologics has signed a strategic cooperation agreement...
Sirnaomics Ltd Partners with Edirna Inc. to Advance RNA Editing Therapy
Sirnaomics Ltd (HKG: 2257), a leading company in the field of RNA therapeutics, has announced...